ImmunologybioRxivPreprint
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects against heterologous challenge with B.1.1.7 and B.1.351 virus variants in Syrian golden hamsters
K. M. Wuertz, E. Barkei, W.-h. Chen…·Vasan
This study evaluates a SARS-CoV-2 spike ferritin nanoparticle vaccine's effectiveness against B.1.1.7 and B.1.351 variants in hamsters, showing protection against disease and viral replication.
DOI 10.1101/2021.06.16.448525